Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Zoetis Inc.
  6. Summary
    ZTS   US98978V1035

ZOETIS INC.

(ZTS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/26/2021 07/27/2021 07/28/2021 07/29/2021 07/30/2021 Date
200.82(c) 201.87(c) 203.27(c) 204.12(c) 202.7(c) Last
1 119 985 1 618 217 1 363 750 1 114 805 2 420 646 Volume
-1.36% +0.52% +0.69% +0.42% -0.70% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 7 604 M - -
Net income 2021 1 931 M - -
Net Debt 2021 2 964 M - -
P/E ratio 2021 48,9x
Yield 2021 0,44%
Sales 2022 8 202 M - -
Net income 2022 2 153 M - -
Net Debt 2022 1 945 M - -
P/E ratio 2022 43,3x
Yield 2022 0,50%
Capitalization 96 235 M 96 235 M -
EV / Sales 2021 13,0x
EV / Sales 2022 12,0x
Nbr of Employees 11 300
Free-Float 94,4%
More Financials
Company
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within... 
Sector
Pharmaceuticals
Calendar
08/05Earnings Release
More about the company
Ratings of Zoetis Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about ZOETIS INC.
07/27ZOETIS : BofA Securities Adjusts Zoetis' Price Objective to $225 From $185 Amid ..
MT
07/19GLOBAL MARKETS LIVE : Zoom, Facebook, Toyota, Canon, Partners Group...
07/16Today on Wall Street: Retail sales pick up unexpectedly
07/16ZOETIS : Raymond James Downgrades Zoetis to Market Perform From Outperform
MT
07/16ANALYST RECOMMENDATIONS : Blackrock, Cintas, Hammerson, US Bancorp, Wells Fargo...
07/13ZOETIS : Cantor Fitzgerald Adjusts Zoetis PT to $238 From $210, Maintains Overwe..
MT
07/02ZOETIS : Donates COVID-19 Vaccines to Help Support the Health of Zoo Animals
BU
06/30ZOETIS : to Host Webcast and Conference Call on Second Quarter 2021 Financial Re..
BU
06/14Fiserv Appoints Wafaa Mamilli to Board of Directors
AQ
06/10ZOETIS : A.L.P.H.A. Initiative Improves Livestock Health and Farmers' Livelihood..
BU
06/03ZOETIS : Releases 2020 Sustainability Report and Creates the Zoetis Foundation, ..
BU
06/01Zoetis Adds Devices for Use in Regenerative Medicine Therapies to Growing Equ..
CI
06/01ZOETIS : Adds Devices for Use in Regenerative Medicine Therapies to its Growing ..
PU
05/28ZOETIS : Argus Adjusts Zoetis' Price Target to $195 From $185, Maintains Buy Rat..
MT
05/27ZOETIS : to Participate in the William Blair 41st Annual Growth Stock Conference
BU
More news
News in other languages on ZOETIS INC.
07/19EN DIRECTO DESDE LOS MERCADOS : Inditex, Ferrari, Capgemini, Toyota, Zoom, Faceb..
07/19MADRID STOCK EXCHANGE : El plan no sale exactamente como estaba previsto
07/19STOCK MARKET PARIS : Le plan ne se déroule pas tout à fait comme prévu
07/19EN DIRECT DES MARCHES : Vivendi, Capgemini, Ubisoft, Ferrari, Ingersoll, Valneva..
07/16Hoy en Wall Street: Las ventas minoristas repuntan inesperadamente
More news
Analyst Recommendations on ZOETIS INC.
More recommendations
Chart ZOETIS INC.
Duration : Period :
Zoetis Inc. Technical Analysis Chart | ZTS | US98978V1035 | MarketScreener
Technical analysis trends ZOETIS INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 202,70 $
Average target price 204,00 $
Spread / Average Target 0,64%
EPS Revisions
Managers and Directors
Kristin C. Peck Chief Executive Officer & Director
Wetteny Joseph CFO, EVP & Head-Business Development
Michael B. McCallister Non-Executive Chairman
Catherine Ann Knupp Executive VP, President-Research & Development
Wafaa Mamilli Chief Information & Digital Officer
Sector and Competitors
1st jan.Capi. (M$)
ZOETIS INC.22.48%96 235
ELANCO ANIMAL HEALTH INCORPORATED18.91%17 250
DECHRA PHARMACEUTICALS PLC44.06%7 479
VIRBAC43.07%3 408
JINYU BIO-TECHNOLOGY CO., LTD.-15.08%3 071
WUHAN KEQIAN BIOLOGY CO.,LTD-31.68%2 045